skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

医薬品企業など45,000社超のヘルスケア企業情報データベース

Medtrack(メドトラック)は、企業発表情報、学会発表、論文、レジストリーサイトなどの公開情報をもとに、ヘルスケア関連企業の事業活動情報を収録しています。

Medtrackの強み:

  • ヘルスケア産業最高レベルを誇る情報収集量
  • 独自のライセンス、提携情報
  • 800疾患以上の疫学レポートを収録
  • DDT(Drug Delivery Technology)の収録
  • 収録情報はエクセルやPDFへのダウンロードが可能

 

売上予測は証券会社3社のアナリストによる平均値にて算出されており、今後5年間を予測しています。医薬品受託製造機関から研究開発機関、テクノロジー系企業や化学メーカーにいたるまで、これらのヘルスケア関連企業の製品やディール活動、財務状況、特許情報などあらゆる情報をモニターしています。

お客様の目的に合わせて、下記の項目で検索ができます:

  • 企業情報(経営層メンバー、売上、企業発表情報など)
  • 薬剤情報(上市品、パイプライン、特許情報、売上)
  • DDT情報(Drug Delivery Technology)
  • 提携情報、など

 

下記の分析ツールをご利用になれます。Medtrackに収録された情報を目的に応じてシンプルに抽出できます。

  • 疫学レポートサーチツール
  • 人事情報検索
  • 情報分析ツール
  • 売上分析ツール
  • 提携情報分析ツール
  • 研究開発費分析ツール
  • ニュース検索

 

Medtrackのデータセットは拡大し続けています。以下のソースから収集されています。

  • 1,800以上の適応症
  • 181,000種類以上の薬剤
  • 2,500以上のドラッグデリバリーテクノロジー
  • 44,000社以上の会社情報
  • 143,000件以上のディール情報
  • 248,000以上の経営幹部プロフィール

このサービスの特徴

無料の最新記事&レポート

  • Biomedtracker: 開発中医薬品をFDA承認確率で評価

    Biomedtracker Q3 2019 Outlook Report Extract

    29 Jul 2019

    In this report, we cover catalysts from 27 drugs, devices and diagnostics expected to occur in Q3 2019. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided. These data points were provided using a combination of Pharmapremia, Informa’s drug development benchmarking product utilizing Biomedtracker’s LOA data to assist in informed decisions about drug pipeline prioritization, partnerships, and acquisitions, and drug approval data from Biomedtracker.   

    Topic drug-development-landscape drug-review research strategy

  • Datamonitor Healthcare: 医療用医薬品の市場調査レポート, Biomedtracker: 開発中医...

    2019 Q3 Outlook Webinar

    By Hardik Patel 15 Jul 2019

    Informa Pharma Intelligence presents an essential, free session during which industry analysts present their data-driven views about what to expect during the third quarter of 2019. 

    Topic immuno-oncology infectious-diseases

  • Meddevicetracker: 医療機器の市場調査分析・データベース, Biomedtracker: 開発中医薬品を...

    When Part of the Picture Isn't Enough

    05 Jul 2019

    Staying on top of what’s going in the competitive Medtech market and getting a complete view of the competitive landscape and current market trends is critical to your business. Often, this essential information is fragmented and difficult to find, and gathering and synthesizing it is tedious and time consuming. Now, Biomedtracker puts this critical information at your fingertips, saving you time and effort. The new “Associated Products” section on relevant Biomedtracker Drug Profile pages shows you the full competitive landscape – including drugs, devices, and diagnostics – with a single search.

    Topic business-strategies medtech

  • Datamonitor Healthcare: 医療用医薬品の市場調査レポート, Biomedtracker: 開発中医...

    Q1 Outlook Webinar: Key Catalysts and their Impact on Pharma Markets

    02 Jul 2019

    Find out which market-moving events and catalysts to watch for during the Q1 Outlook Webinar - Key catalysts and their impact on pharma markets.

    Topic drug-approval drug-development-landscape drug-review

  • Biomedtracker: 開発中医薬品をFDA承認確率で評価

    Biomedtracker: Catalyst Roundup 2018 Q4

    02 Jul 2019

    A Review of Select Catalysts from Last Quarter’s Outlook Report.

    Topic clinical-trials drug-approval drug-review drug-development-landscape

  • Meddevicetracker: 医療機器の市場調査分析・データベース, Biomedtracker: 開発中医薬品を...

    Q2 2019 Outlook Report

    03 May 2019

    In this report, we cover catalysts from 25 drugs, devices and diagnostics expected to occur in Q2 2019. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided.

    Topic drug-approval drug-development-landscape drug-review

  • Biomedtracker: 開発中医薬品をFDA承認確率で評価, Datamonitor Healthcare: 医療...

    December 2018 National Influenza Week

    10 Apr 2019

    3 – 9 December is National Influenza Vaccination Week, a national awareness week focused on highlighting the importance of influenza vaccination. In this free KOL Insight Interview excerpt from Datamonitor Healthcare, read what key opinion leaders from the UK and US in Infectious Diseases have to say about current efforts to combat influenza with seasonal influenza vaccines:

    Topic influenza-virus infectious-diseases

  • Biomedtracker: 開発中医薬品をFDA承認確率で評価

    Biomedtracker 2018 Early Outlook Report

    10 Apr 2019

    What's on the horizon for pharma in 2018? Find out with Biomedtracker's Early 2018 Outlook Report extract. Download free extracts from this essential report, which investigates the catalysts expected to occur in the first part of the year for 21 different drugs.

    Topic drug-development-landscape

  • Biomedtracker: 開発中医薬品をFDA承認確率で評価, Meddevicetracker: 医療機器の市場調...

    Biomedtracker: Early 2019 Outlook Report Extract

    10 Apr 2019

    In this report, we cover catalysts from 23 drugs, devices and diagnostics expected to occur in early 2019.

    Topic drug-approval drug-review medtech

  • Biomedtracker: 開発中医薬品をFDA承認確率で評価

    Q4 Outlook Webinar - Key Catalysts and their Impact on Pharma Markets

    19 Nov 2018

    Understand important upcoming milestones that will impact the likelihood of drug approval or future sales potential for key therapies during a free webinar from Informa Pharma Intelligence, "Q4 Outlook Webinar - Key Catalysts and their Impact on Pharma Markets".

    Topic drug-development-landscape

  • Biomedtracker: 開発中医薬品をFDA承認確率で評価

    Biomedtracker Q4 2018 Outlook Report

    19 Oct 2018

    Find out what’s in store for the remainder of 2018 with your copy of the Biomedtracker Q4 2018 Outlook Report Extract. This essential analysis of expected Q4 catalysts for 27 drugs is now available to you – for free. Drawn from the full report of the same name, this vital resource explores the likelihood of phase/PDUFA review success and overall Likelihood of Approval (LOA) based on a drug’s phase, drug class, and disease group.

    Topic drug-development-landscape

  • Biomedtracker: 開発中医薬品をFDA承認確率で評価

    Pharma Partnering Trends Revealed Whitepaper

    12 Oct 2018

    Make the most of BIO-Europe 2018 with essential partnering information from Informa Pharma Intelligence. Our insightful whitepaper, Pharma Partnering Trends Revealed: 2018 Edition, contains critical information on the landscape for biotech partnerships, and is now available for you to download – free.

  • Biomedtracker

    Biomedtracker Q3 2018 Outlook Infographic

    22 Aug 2018

    For a look at the outcomes for predicted Q2 2018 catalysts, we invite you to download a free copy of the data-rich Catalyst Roundup infographic from Biomedtracker. This informative graphic takes a look at the outcomes for two major catalysts featured in Biomedtracker’s insightful Q2 2018 Outlook Report.

    Topic drug-development-landscape

  • Biomedtracker

    Biomedtracker Q3 2018 Outlook Report Extract

    15 Aug 2018

    Download an extract of the data-rich resource: Biomedtracker’s Q3 2018 Outlook Report. This latest installment in Biomedtracker’s ongoing quarterly reports contains expected drug catalyst predictions, important clinical and regulatory milestones, and Large Impact catalysts for the upcoming quarter. 

    Topic drug-development-landscape

  • Scrip: 世界の医療用医薬品&製薬産業に関するニュース, Biomedtracker: 開発中医薬品をFDA承認確率...

    ASCO Essentials Webinar 2018 Recording

    29 May 2018

    Just in time for your 2018 ASCO Annual Meeting planning, join analysts from Datamonitor Healthcare, Biomedtracker, Citeline, Scrip, and Pink Sheet for their expert opinions on what you need to know to get the most from the meeting. Let our experts present their top picks from the thousands of abstracts being presented at ASCO.

    Topic clinical-trials

医薬品産業専門のジャーナリスト&アナリスト

Management

Patricia Reilly

Management, VP, Intelligence Alliances and Product Unification
Patricia Reilly

Patricia specializes in

  • CNS
  • Immunology and Inflammation
  • Oncology

+27 year(s) experience

Management

Gail Parziale

Management, ​Head of Intelligence Editorial Operations
Gail Parziale

Gail specializes in

  • Commercial Strategy
  • Clinical Trials

+22 year(s) experience

Management

Christine Blazynski, PhD

Management, Senior Product Manager, Special Projects
Christine Blazynski, PhD

Christine specializes in

  • Clinical Trials
  • Clinical trial strategy
  • Clinical trial benchmark analysis
  • Clinical trend analysis
  • Biopharma pipeline strategy

+21 year(s) experience

製品説明を兼ねた無料デモ&お問い合わせ

専任スタッフによる詳しい説明を兼ねた無料デモンストレーションを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

ご質問等ございましたらお気軽にご連絡下さい。

日本(平日:9時~18時)
電話:+81 (0)3 6273 4260
Email:inquiry.jp@informa.com

オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。